Clinical evaluation of high-frequency intermittent replacement hemodiafiltration

Clinical evaluation of high-frequency intermittent replacement hemodiafiltration - Clinical evaluation of high-frequency intermittent replacement hemodiafiltration

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000057713

Enrollment

Registered

2025-04-26

Start date

2025-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with end-stage renal failure undergoing postdilution online hemodiafiltration

Interventions

High-frequency intermittent hemodiafiltration with fluid replacement volume of 10.4L and 12.7L will be performed once a week

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing post-dilution hemodiafiltration

Exclusion criteria

Exclusion criteria: 1. Patients who cannot provide written informed consent 2. Patients who are deemed inappropriate by the principal investigator

Design outcomes

Primary

Measure	Time frame
Removal rate and amount of alfa1-microglobulin, amount of albumin leakage	—

Secondary

Measure	Time frame
Removal rate and amount of urea, creatinine, and phosphorus Material costs and waste	—

Countries

Japan

Contacts

Public ContactHiroyuki Michiwaki

Social Medical Corporation Kawashimakai Department of Clinical Engineering

michiwaki@khg.or.jp088-631-0110

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026